Matthew Wever

Matthew Wever serves as the Senior Director of National Accounts & GPOs for the US Oncology Division at Bayer since October 2025, following a long tenure at Incyte where responsibilities included leading market access initiatives and strategic account management. With extensive experience in the oncology and hematology sectors, Matthew has previously held roles such as Director of Market Access at Incyte, Senior Clinical Sales Specialist at Allos Therapeutics, and Oncology District Manager at Eisai US, among others. Matthew's career is marked by significant achievements, including increasing sales for Zyvox by 123% during its launch year at Pfizer and managing multi-million dollar revenues across various pharmaceutical companies. Educational qualifications include a BS in Business Administration with a focus on Marketing from Oklahoma State University and further studies at The Johns Hopkins University - Carey Business School.